Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Cardiovasc Eng Technol ; 5(1): 119-131, 2014 Mar 01.
Article in English | MEDLINE | ID: mdl-24683428

ABSTRACT

PURPOSE: Demonstrate a novel manufacturing method to generate extracellular matrix scaffolds from cardiac fibroblasts (CF-ECM) as a therapeutic mesenchymal stem cell-transfer device. MATERIALS AND METHODS: Rat CF were cultured at high-density (~1.6×105/cm2) for 10-14 days. Cell sheets were removed from the culture dish by incubation with EDTA and decellularized with water and peracetic acid. CF-ECM was characterized by mass spectrometry, immunofluorescence and scanning electron microscopy. CF-ECM seeded with human embryonic stem cell derived mesenchymal stromal cells (hEMSCs) were transferred into a mouse myocardial infarction model. 48 hours later, mouse hearts were excised and examined for CF-ECM scaffold retention and cell transfer. RESULTS: CF-ECM scaffolds are composed of fibronectin (82%), collagens type I (13%), type III (3.4%), type V (0.2%), type II (0.1%) elastin (1.3%) and 18 non-structural bioactive molecules. Scaffolds remained intact on the mouse heart for 48 hours without the use of sutures or glue. Identified hEMSCs were distributed from the epicardium to the endocardium. CONCLUSIONS: High density cardiac fibroblast culture can be used to generate CF-ECM scaffolds. CF-ECM scaffolds seeded with hEMSCs can be maintained on the heart without suture or glue. hEMSC are successfully delivered throughout the myocardium.

2.
J. physiol. biochem ; 69(2): 165-175, jun. 2013.
Article in English | IBECS | ID: ibc-121965

ABSTRACT

Consumption of a high-fat diet (HFD) in experimental animal models initiates a series of molecular events and outcomes, including insulin resistance and obesity, that mimic the metabolic syndrome in humans. The relationship among, and order of, the molecular events linking a diet high in fat to pathologies is often unclear. In the present study, we provide several novel insights into the relationship between a HFD and AMP-activated protein kinase (AMPK), a key regulator of cellular metabolism and whole-body energy balance. HFD substantially decreased the activities of both isoforms of AMPK in white adipose tissue, heart, and liver. These decreases in AMPK activity occurred in the absence of decreased AMPK transcription, systemic inflammation, hyperglycemia, or elevated levels of free fatty acids. The HFD-induced decrease in AMPK activity was associated with systemic insulin resistance and hyperleptinemia. In blood, >98 % of AMPK activity was localized in agranulocytes as the á1 isoform. In contrast to the solid tissues studied, AMPK activities were not altered by HFD in granulocytes or agranulocytes. We conclude that HFD-induced obesity causes a broad, non-tissue, or isoform-specific lowering of AMPK activity. Given the central position AMPK plays in whole-body energy balance, this decreased AMPK activity may play a previously unrecognized role in obesity and its associated pathologies (AU)


Subject(s)
Animals , Rats , Dietary Fats/pharmacokinetics , Mitogen-Activated Protein Kinases/pharmacokinetics , Disease Models, Animal , Obesity/physiopathology
3.
J Physiol Biochem ; 69(2): 165-75, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22941749

ABSTRACT

Consumption of a high-fat diet (HFD) in experimental animal models initiates a series of molecular events and outcomes, including insulin resistance and obesity, that mimic the metabolic syndrome in humans. The relationship among, and order of, the molecular events linking a diet high in fat to pathologies is often unclear. In the present study, we provide several novel insights into the relationship between a HFD and AMP-activated protein kinase (AMPK), a key regulator of cellular metabolism and whole-body energy balance. HFD substantially decreased the activities of both isoforms of AMPK in white adipose tissue, heart, and liver. These decreases in AMPK activity occurred in the absence of decreased AMPK transcription, systemic inflammation, hyperglycemia, or elevated levels of free fatty acids. The HFD-induced decrease in AMPK activity was associated with systemic insulin resistance and hyperleptinemia. In blood, >98 % of AMPK activity was localized in agranulocytes as the α1 isoform. In contrast to the solid tissues studied, AMPK activities were not altered by HFD in granulocytes or agranulocytes. We conclude that HFD-induced obesity causes a broad, non-tissue, or isoform-specific lowering of AMPK activity. Given the central position AMPK plays in whole-body energy balance, this decreased AMPK activity may play a previously unrecognized role in obesity and its associated pathologies.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Adipose Tissue, White/metabolism , Diet, High-Fat , Hyperglycemia/metabolism , Inflammation/metabolism , Adipose Tissue, Brown/metabolism , Animals , Dietary Fats , Inflammation/pathology , Male , Obesity/metabolism , Obesity/pathology , Organ Specificity , Rats , Rats, Sprague-Dawley
4.
Am J Physiol Regul Integr Comp Physiol ; 301(2): R473-83, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21593427

ABSTRACT

Recent studies indicate that a substantial amount of metabolically active brown adipose tissue (BAT) exists in adult humans. Given the unique ability of BAT to convert calories to heat, there is intense interest in understanding the regulation of BAT metabolism in hopes that its manipulation might be an effective way of expending excess calories. Because of the established role of AMP-activated protein kinase (AMPK) as a "metabolic master switch" and its extremely high levels of activity in BAT, it was hypothesized that AMPK might play a central role in regulating BAT metabolism. To test this hypothesis, whole body α(1)-AMPK(-/-) (knockout) and wild-type mice were studied 1) under control (room temperature) conditions, 2) during chronic cold exposure (14 days at 4°C), and 3) during acute nonshivering thermogenesis (injection of a ß(3)-adrenergic agonist). Under control conditions, loss of α(1)-AMPK resulted in downregulation of two important prothermogenic genes in BAT, thyrotropin-releasing hormone (-9.2-fold) and ciliary neurotrophic factor (-8.7-fold). Additionally, it caused significant upregulation of α(2)-AMPK activity in BAT, white adipose tissue, and liver, but not cardiac or skeletal muscle. During acute nonshivering thermogenesis and chronic cold exposure, body temperature was indistinguishable in the α(1)-AMPK(-/-) and wild-type mice. Similarly, the degree of cold-induced hyperphagia was identical in the two groups. We conclude that α(1)-AMPK does not play an obligatory role in these processes and that adaptations to chronic loss of α(1)-AMPK are able to compensate for its loss via several mechanisms.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Body Temperature Regulation/physiology , Cold Temperature , Gene Expression Regulation, Enzymologic/physiology , Hyperphagia/metabolism , AMP-Activated Protein Kinases/genetics , Adaptation, Physiological , Adipose Tissue, Brown/metabolism , Animals , Body Temperature Regulation/genetics , Body Weight , Genotype , Hyperphagia/genetics , Mice , Mice, Knockout , Shivering/genetics , Shivering/physiology
5.
Age (Dordr) ; 33(3): 351-61, 2011 Sep.
Article in English | MEDLINE | ID: mdl-20922487

ABSTRACT

The aged heart displays a loss of cardiomyocyte number and function, possibly due to the senescence and decreased regenerative potential that has been observed in some cardiac progenitor cells. An important cardiac progenitor that has not been studied in the context of aging is the cardiac side population (CSP) cell. To address this, flow cytometry-assisted cell sorting was used to isolate CSP cells from adult (6-10 months old) and aged (24-32 months old) C57Bl/6 mice that were fed either a control diet or an anti-aging diet (caloric restriction, CR). Aging caused a 2.3-fold increase in the total number of CSP cells and a 3.2-fold increase in the cardiomyogenic sca1(+)/CD31(-) subpopulation. Aging did not affect markers of proliferation or senescence, including telomerase activity and expression of cell cycle genes, in sca1(+)/CD31(-) CSP cells. In contrast, the aged cells had reduced expression of genes associated with differentiation, including smooth muscle actin and cardiac muscle actin (5.1- and 3.2-fold, respectively). None of these age effects were altered by CR diet. Therefore, it appears that the manner in which CSP cells age is distinct from the aging of post-mitotic tissue (and perhaps other progenitor cells) that can often be attenuated by CR.


Subject(s)
Aging/physiology , Caloric Restriction , Myocardium/cytology , Stem Cells/physiology , Animals , Cell Proliferation , Cellular Senescence , Heart/physiology , Male , Mice , Mice, Inbred C57BL , Models, Animal
6.
Age (Dordr) ; 33(2): 107-18, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20628827

ABSTRACT

White adipose tissue is a promising source of mesenchymal stem cells. Currently, little is known about the effect of age and caloric restriction (CR) on adipose-derived stem cells (ASC). This is important for three reasons: firstly, age and CR cause extensive remodeling of WAT; it is currently unknown how this remodeling affects the resident stem cell population. Secondly, stem cell senescence has been theorized as one of the causes of aging and could reduce the utility of a stem cell as a reagent. Thirdly, the mechanism by which CR extends lifespan is currently not known, one theory postulates that CR maintains the resident stem cell population in youthful "fit" state. For the purpose of this study, we define ASC as lineage negative (lin(-))/CD34(+(low))/CD31(-). We show that aging increases the abundance of ASC and the expression of Cdkn2a 9.8-fold and Isl1 60.6-fold. This would suggest that aging causes an accumulation of non-replicative ASC. CR reduced the percentage of ASC in the lin(-) SVF while also reducing colony forming ability. Therefore, CR appears to have anti-proliferative effects on ASC that may be advantageous from the perspective of cancer, but our data raises the possibility that it may be disadvantageous for regenerative medicine applications.


Subject(s)
Adipose Tissue, White/cytology , Aging/physiology , Caloric Restriction , Cell Proliferation , Mesenchymal Stem Cells/cytology , Animals , Antigens, CD34/analysis , Cell Count , Epididymis/anatomy & histology , Epididymis/cytology , Male , Mesenchymal Stem Cells/chemistry , Mesenchymal Stem Cells/metabolism , Mice , Mice, Inbred C57BL , Platelet Endothelial Cell Adhesion Molecule-1/analysis , Telomerase/metabolism , beta-Galactosidase/metabolism
7.
Exp Gerontol ; 43(3): 146-53, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18053669

ABSTRACT

Calorie restriction extends lifespan by decreasing the rate of tumor formation, an effect occurring within 8 weeks of initiating a restricted diet. Our goal was to define how the first weeks of a calorie restricted diet (60% of ad libitum calories) affects putative mediators of the calorie restriction phenotype, focusing on regulators of fatty acid biosynthesis. In C57Bl/6 mice, insulin decreased over 50% (p<0.05) during the first week of calorie restriction whereas IGF-1 was unaffected. In the liver, PPARgamma mRNA fell to 13% of baseline after 1 week of calorie restriction (p<0.05), whereas hepatic SREBP-1c and SIRT1 mRNA levels were unaffected. No changes in abdominal or subcutaneous adipose tissue were observed until after 4 weeks of caloric restriction. We conclude that calorie restriction-induced decreases in insulin and hepatic PPARgamma are rapid enough to support a role for these molecules in triggering the initial phase of the calorie restriction phenotype.


Subject(s)
Caloric Restriction , Down-Regulation , Insulin/blood , Liver/metabolism , PPAR gamma/biosynthesis , Adipose Tissue/metabolism , Animals , Blood Glucose/metabolism , Blotting, Western/methods , Insulin/biosynthesis , Insulin-Like Growth Factor I/metabolism , Male , Mice , Mice, Inbred C57BL , PPAR gamma/genetics , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Sirtuin 1 , Sirtuins/biosynthesis , Sirtuins/genetics , Sterol Regulatory Element Binding Protein 1/biosynthesis , Sterol Regulatory Element Binding Protein 1/genetics , Time Factors
8.
J Nutr ; 137(10): 2247-51, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17885006

ABSTRACT

Restricting energy intake while supplying adequate micronutrients slows aging and extends maximal lifespan, whereas loss of body weight with exercise training does not. Our goal was to test the hypothesis that weight loss via energy restriction (ER) alters body composition in a way that is: 1) distinct from exercise-induced weight loss; and 2) conserved regardless of the age at which ER is initiated. An experimental model was developed where matched losses in weight could be induced with 6 mo of ER (approximately 55% of ad libitum energy intake) or voluntary exercise on a running wheel in adult (12 mo) male C57BL/6 mice and a similar amount of ER-induced weight loss could be induced in aged mice (24 mo). Using dual-energy X-ray absorptiometry, we determined that ER and exercise in the 12-mo-old mice caused nearly identical changes in the amount and distribution of adipose tissue in the 12-mo group, with 70-75% of overall weight loss due to fat loss. Decreased prostate and epididymal fat weights were similar with ER and exercise, and heart weight was unaffected by either intervention. In contrast to the adult mice, in aged mice, ER caused primarily a loss of lean body mass including the heart, with no decreased prostate or fat pad weight. Bone mineral density was decreased by ER but not exercise in the adult mice, an effect not seen in the aged mice. Our data refute the hypothesis that ER causes a unique change in body composition that is conserved across age and suggest that fat loss may not be an essential component of the anti-aging effects of ER.


Subject(s)
Aging/physiology , Body Composition/physiology , Energy Intake/physiology , Food Deprivation/physiology , Animals , Body Weight , Male , Mice , Mice, Inbred C57BL , Motor Activity
9.
J Physiol ; 580(Pt. 2): 677-84, 2007 Apr 15.
Article in English | MEDLINE | ID: mdl-17272339

ABSTRACT

AMPK (adenosine monophosphate-activated protein kinase), a key regulator of cellular energy metabolism and whole-body energy balance, is present in brown adipose tissue but its role in regulating the acute metabolic state and chronic thermogenic potential of this metabolically unique tissue is unknown. To address this, the AMPK signalling system in brown and white adipose tissue was studied in C57Bl/6 mice under control conditions, during acute and chronic cold exposure, and during chronic adrenergic stimulation. In control mice AMPK activity in brown adipose tissue was higher than in any tissue yet reported (3-fold the level in liver) secondary to a high level of expression of the alpha1 isoform. During the first day of cold, a time of intense non-shivering thermogenesis, AMPK activity remained at basal levels. However, chronic (>7 days) cold caused a progressive increase in brown adipose tissue AMPK activity secondary to increased expression of the alpha1 isoform. To investigate the signalling pathway involved, noradrenaline (norepinephrine) and the beta(3)-adrenergic-specific agonist CL 316, 243 were given for 14 days. This increased uncoupling protein-1 content in brown adipose tissue, but not AMPK activity. In white adipose tissue 15 days of cold increased alpha1 AMPK activity 98 +/- 20%, an effect reproduced by chronic noradrenaline or CL 316 243. We conclude that chronic cold not only increases AMPK activity in brown and white adipose tissue, but that it does so via distinct signalling pathways. Our data are consistent with AMPK acting primarily as a regulator of chronic thermogenic potential in brown adipose tissue, and not in the acute activation of non-shivering thermogenesis.


Subject(s)
Acclimatization/physiology , Adipose Tissue, Brown/metabolism , Adipose Tissue, White/metabolism , Cold Temperature , Protein Kinases/metabolism , AMP-Activated Protein Kinase Kinases , Acetyl-CoA Carboxylase/metabolism , Adrenergic Agents/pharmacology , Animals , Male , Mice , Mice, Inbred C57BL , Phosphorylation , Up-Regulation
10.
J Gerontol A Biol Sci Med Sci ; 60(1): 21-7, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15741278

ABSTRACT

Despite the central role of adenosine monophosphate-activated protein kinase (AMPK) in the cellular stress response, it is unknown whether age-related changes in AMPK activity play a role in the diminished stress tolerance that is characteristic of aging. To address this question, we determined in the mouse liver how normal aging affects 1) basal AMPK activity, and 2) the degree to which AMPK activity is increased by in vivo hypoxia. We found that the basal activity of AMPK alpha1, but not alpha2, was higher in livers from 24-month-old mice compared to those from 5-month-old mice. Furthermore, while hypoxia elevated AMPK alpha1 and alpha2 activities in livers from 5-month-old mice, hypoxia failed to increase the activity of either isoform of AMPK in 24-month-old mice. These findings suggest that age-associated changes in hepatic AMPK activity may play a role in the physiological changes that occur in the liver with normal aging.


Subject(s)
Aging/metabolism , Hypoxia/enzymology , Liver/enzymology , Multienzyme Complexes/metabolism , Protein Serine-Threonine Kinases/metabolism , AMP-Activated Protein Kinases , Animals , Mice , Mice, Inbred C57BL
11.
Am J Physiol Regul Integr Comp Physiol ; 287(5): R1270-5, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15284083

ABSTRACT

Although a diminished ability of tissues and organisms to tolerate stress is a clinically important hallmark of normal aging, little is known regarding its biochemical basis. Our goal was to determine whether age-associated changes in AMP-activated protein kinase (AMPK), a key regulator of cellular metabolism during the stress response, might contribute to the poor stress tolerance of aged cardiac and skeletal muscle. Basal AMPK activity and the degree of activation of AMPK by AMP and by in vivo hypoxemia (arterial Po2 of 39 mmHg) were measured in cardiac and skeletal muscle (gastrocnemius) from 5- and 24-mo-old C57Bl/6 mice. In the heart, neither basal AMPK activity nor its allosteric activation by AMP was affected by age. However, after 10 min of hypoxemia, the activity of alpha2-AMPK, but not alpha1-AMPK, was significantly higher in the hearts from old than from young mice (P < 0.005), this difference being due to differences in phosphorylation of alpha2-AMPK. Significant activation of AMPK in the young hearts did not occur until 30 min of hypoxemia (P < 0.01), stress that was poorly tolerated by the old mice (mortality = 67%). In contrast, AMPK activity in gastrocnemius muscle was unaffected by age or hypoxemia. We conclude that the age-associated decline in hypoxic tolerance in cardiac and skeletal muscle is not caused by changes in basal AMPK activity or a blunted AMPK response to hypoxia. Activation of AMPK by in vivo hypoxia is slower and more modest than might be predicted from in vitro and ex vivo experiments.


Subject(s)
Aging/physiology , Heart/growth & development , Hypoxia/enzymology , Multienzyme Complexes/metabolism , Muscle, Skeletal/enzymology , Muscle, Skeletal/growth & development , Myocardium/enzymology , Protein Serine-Threonine Kinases/metabolism , AMP-Activated Protein Kinases , Animals , Blood Gas Analysis , Glycolysis/physiology , Isoenzymes/metabolism , Mice , Mice, Inbred C57BL , Oxidation-Reduction , Oxygen/blood , Phosphorylation , Survival Analysis
12.
Am J Physiol Endocrinol Metab ; 287(5): E1032-7, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15251868

ABSTRACT

Activation of adenosine monophosphate-activated protein kinase (AMPK) plays a central role in allowing cells to adapt to nutrient deprivation in vitro. This link between AMPK activity and nutritional status has raised the possibility that AMPK plays a role in the metabolic adaptation to acute and chronic nutritional stress. However, the effects of nutritional stress on AMPK activity in vivo have not been systematically evaluated. To address this, we measured the effects of 24 h of fasting and 4 mo of caloric restriction (CR) on AMPK alpha 1 and -alpha 2 activities in heart, skeletal muscle, and liver in mice. Although fasting caused the expected changes in body weight, plasma leptin, and free fatty acids, it did not increase AMPK activity in heart or skeletal muscle and only increased liver AMPK activity by approximately 20% (P = 0.10). Likewise, CR caused the expected changes in body weight, plasma leptin, and free fatty acids but did not alter AMPK activity in any of the three tissues. Although CR did not alter liver AMPK activity, it dramatically decreased the amount of phosphorylated acetyl-CoA carboxylase, and this was found to be due to decreased protein expression. Plasma leptin, a putative activator of AMPK, varied eightfold across the four groups of mice in the absence of changes in AMPK activity in any tissue. We conclude that, although the metabolic adaptations to fasting and CR include changes in plasma leptin concentration and phosphorylated acetyl-CoA carboxylase, these effects occur without changes in AMPK activity.


Subject(s)
Caloric Restriction , Fasting/metabolism , Liver/enzymology , Multienzyme Complexes/metabolism , Muscle, Skeletal/enzymology , Myocardium/enzymology , Protein Serine-Threonine Kinases/metabolism , AMP-Activated Protein Kinases , Acetyl Coenzyme A/metabolism , Adaptation, Physiological , Analysis of Variance , Animals , Body Weight/physiology , Enzyme Activation , Fatty Acids, Nonesterified/metabolism , Leptin/blood , Male , Mice , Mice, Inbred C57BL , Nutritional Status/physiology
13.
J Biol Chem ; 278(15): 13356-66, 2003 Apr 11.
Article in English | MEDLINE | ID: mdl-12551945

ABSTRACT

The ATP-binding cassette transporter A1 (ABCA1) participates in the efflux of cholesterol from cells. It remains unclear whether ABCA1 functions to efflux cholesterol across the basolateral or apical membrane of the intestine. We used a chicken model of ABCA1 dysfunction, the Wisconsin hypoalpha mutant (WHAM) chicken, to address this issue. After an oral gavage of radioactive cholesterol, the percentage appearing in the bloodstream was reduced by 79% in the WHAM chicken along with a 97% reduction in the amount of tracer in high density lipoprotein. In contrast, the percentage of radioactive cholesterol absorbed from the lumen into the intestine was not affected by the ABCA1 mutation. Liver X receptor (LXR) agonists have been inferred to decrease cholesterol absorption through activation of ABCA1 expression. However, the LXR agonist T0901317 decreased cholesterol absorption equally in both wild type and WHAM chickens, indicating that the effect of LXR activation on cholesterol absorption is independent of ABCA1. The ABCA1 mutation resulted in accumulation of radioactive cholesterol ester in the intestine and the liver of the WHAM chicken (5.0- and 4.4-fold, respectively), whereas biliary lipid concentrations were unaltered by the WHAM mutation. In summary, ABCA1 regulates the efflux of cholesterol from the basolateral but not apical membrane in the intestine and the liver.


Subject(s)
ATP-Binding Cassette Transporters/metabolism , Chickens/genetics , Cholesterol, Dietary , Cholesterol/metabolism , Intestinal Absorption/physiology , ATP Binding Cassette Transporter 1 , Animals , Biological Transport , Cholesterol/blood , Lipoproteins/blood , Models, Biological , Mutation
14.
J Lipid Res ; 43(10): 1610-7, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12364545

ABSTRACT

The Wisconsin hypoalpha mutant (WHAM) chicken has a >90% reduction in plasma HDL due to hypercatabolism by the kidney of lipid-poor apoA-I. The WHAM chickens have a recessive white skin phenotype caused by a single-gene mutation that maps to the chicken Z-chromosome. This corresponds to human 9q31.1, a chromosomal segment that contains the ATP-binding cassette protein-1 (ABCA1) gene, which is mutated in Tangier Disease and familial hypoalphalipoproteinemia. Complete sequencing of the WHAM ABCA1 cDNA identified a missense mutation near the N-terminus of the protein (E89K). The substitution of this evolutionary conserved glutamate residue for lysine in the mouse ABCA1 transporter leads to complete loss of function, resulting principally from defective intracellular trafficking and very little ABCA1 reaching the plasma membrane. The WHAM chicken is a naturally occurring animal model for Tangier Disease.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Chickens/genetics , Mutation, Missense/genetics , ATP Binding Cassette Transporter 1 , ATP-Binding Cassette Transporters/metabolism , Animals , Base Sequence , Carotenoids/blood , Cell Membrane/metabolism , Chickens/blood , Cholesterol/blood , Chromosome Mapping , Disease Models, Animal , Endoplasmic Reticulum/metabolism , HeLa Cells/metabolism , HeLa Cells/ultrastructure , Humans , Lipoproteins/blood , Lipoproteins/genetics , Mice , Microscopy, Confocal , Phenotype , Phospholipids/blood , Phospholipids/genetics , Protein Transport/genetics , Sequence Homology, Nucleic Acid , Tangier Disease/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...